Trinity Biotech (TRIB) Net Income towards Common Stockholders Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Net Income towards Common Stockholders Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -187.11% |
| Sep 30, 2024 | 28.66% |
| Jun 30, 2024 | 62.08% |
| Mar 31, 2024 | 48.54% |
| Dec 31, 2023 | 45.29% |
| Sep 30, 2023 | 32.73% |
| Jun 30, 2023 | -80.64% |
| Mar 31, 2023 | 52.22% |
| Dec 31, 2022 | -186.25% |
| Sep 30, 2022 | -639.36% |
| Jun 30, 2022 | -2,026.00% |
| Mar 31, 2022 | -400.86% |
| Dec 31, 2021 | -138.52% |
| Sep 30, 2021 | -82.73% |
| Jun 30, 2021 | -70.53% |
| Mar 31, 2021 | 42.43% |
| Dec 31, 2020 | 438.11% |
| Sep 30, 2020 | 251.72% |
| Jun 30, 2020 | -78.64% |
| Mar 31, 2020 | 9.86% |